debate: immunomodulator monotherapy use in clinical practice - con
Published 9 years ago • 467 plays • Length 5:28Download video MP4
Download video MP3
Similar videos
-
10:01
debate: immunomodulator monotherapy use in clinical practice - pro
-
17:18
debate: asymptomatic uc patient on an immunomodulator with mucosal inflammation - no biologics
-
21:12
positioning immunomodulators as monotherapies or in combination with biologics
-
19:03
debate: ibd patient on biologic or immunomodulator who develops a malignancy - may continue meds
-
19:10
debate: combination or monotherapy with anti-tnf? - monotherapy
-
18:01
debate: combination or monotherapy with anti-tnf? - combination
-
10:22
debate: asymptomatic uc patient on an immunomodulator with mucosal inflammation - add biologics
-
7:36
debate: is combination therapy necessary if you use anti-tnf? - no, monotherapy will suffice
-
12:12
debate: immunomodulators and anti-tnfs must be stopped when an infection occurs
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
31:51
case discussion: management of infections in ibd patients on immunomodulators and/or biologics
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
11:25
debate: to maintain or not to maintain? immunomodulators vs. pi - yes (imids)
-
11:32
debate: ibd patient on biologic or immunomodulator who develops a malignancy - must stop these meds
-
17:26
debate: to maintain or not to maintain? immunomodulators vs. pi - yes (proteasome inhibitors)
-
13:24
pro: monotherapy using 6-mp or azathioprine for ibd is dead
-
15:59
debate: to maintain or not to maintain? immunomodulators vs. pi - no
-
14:10
con: monotherapy using 6-mp or azathioprine for ibd is not dead yet